{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:09:17Z","timestamp":1793261357125,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-34910-7","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T11:26:56Z","timestamp":1767698816000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Changes in interictal cerebral blood flow observed in migraine patients who respond to anti-calcitonin gene-related peptide therapy"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5758-739X","authenticated-orcid":false,"given":"Masami","family":"Shimoda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5982-5619","authenticated-orcid":false,"given":"Kaori","family":"Hoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9170-5732","authenticated-orcid":false,"given":"Shinri","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4294-7190","authenticated-orcid":false,"given":"Masaaki","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9615-4332","authenticated-orcid":false,"given":"Rie","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5186-5776","authenticated-orcid":false,"given":"Chiaki","family":"Shinohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"key":"34910_CR1","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/head.13529","volume":"59","author":"S Iyengar","year":"2019","unstructured":"Iyengar, S., Johnson, K. W., Ossipov, M. H. & Aurora, S. K. CGRP and the trigeminal system in migraine. Headache 59, 659\u2013681. https:\/\/doi.org\/10.1111\/head.13529 (2019).","journal-title":"Headache"},{"key":"34910_CR2","doi-asserted-by":"publisher","first-page":"H11","DOI":"10.1152\/ajpheart.1994.266.1.H11","volume":"266","author":"KW Hong","year":"1994","unstructured":"Hong, K. W., Pyo, K. M., Lee, W. S., Yu, S. S. & Rhim, B. Y. Pharmacological evidence that calcitonin gene-related peptide is implicated in cerebral autoregulation. Am. J. Physiol. 266, H11\u201316. https:\/\/doi.org\/10.1152\/ajpheart.1994.266.1.H11 (1994).","journal-title":"Am. J. Physiol."},{"key":"34910_CR3","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/s0140-6736(19)32504-8","volume":"394","author":"A Charles","year":"2019","unstructured":"Charles, A. & Pozo-Rosich, P. Targeting calcitonin gene-related peptide: a new era in migraine therapy. Lancet 394, 1765\u20131774. https:\/\/doi.org\/10.1016\/s0140-6736(19)32504-8 (2019).","journal-title":"Lancet"},{"key":"34910_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s10194-024-01741-2","volume":"25","author":"MG Vittorini","year":"2024","unstructured":"Vittorini, M. G. et al. The glymphatic system in migraine and other headaches. J. Headache Pain. 25, 34. https:\/\/doi.org\/10.1186\/s10194-024-01741-2 (2024).","journal-title":"J. Headache Pain"},{"key":"34910_CR5","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1161\/01.Str.0000177886.94134.92","volume":"36","author":"M M\u00fcller","year":"2005","unstructured":"M\u00fcller, M. & Marziniak, M. The linear behavior of the system middle cerebral artery flow velocity and blood pressure in patients with migraine: lack of autonomic control? Stroke 36, 1886\u20131890. https:\/\/doi.org\/10.1161\/01.Str.0000177886.94134.92 (2005).","journal-title":"Stroke"},{"key":"34910_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/biom12060748","author":"Y. Tian","year":"2022","unstructured":"Tian, Y., Zhao, M., Chen, Y., Yang, M. & Wang, Y. The underlying role of the glymphatic system and meningeal lymphatic vessels in cerebral small vessel disease. Biomolecules. https:\/\/doi.org\/10.3390\/biom12060748 (2022).","journal-title":"Biomolecules"},{"key":"34910_CR7","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1177\/0333102419856640","volume":"39","author":"K Kamm","year":"2019","unstructured":"Kamm, K., Straube, A. & Ruscheweyh, R. Calcitonin gene-related peptide levels in tear fluid are elevated in migraine patients compared to healthy controls. Cephalalgia 39, 1535\u20131543. https:\/\/doi.org\/10.1177\/0333102419856640 (2019).","journal-title":"Cephalalgia"},{"key":"34910_CR8","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/ana.26472","volume":"92","author":"A Alpuente","year":"2022","unstructured":"Alpuente, A. et al. Salivary CGRP and erenumab treatment response: towards precision medicine in migraine. Ann. Neurol. 92, 846\u2013859. https:\/\/doi.org\/10.1002\/ana.26472 (2022).","journal-title":"Ann. Neurol."},{"key":"34910_CR9","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1212\/WNL.0b013e3182a6cb72","volume":"81","author":"E Cernuda-Moroll\u00f3n","year":"2013","unstructured":"Cernuda-Moroll\u00f3n, E. et al. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine. Neurology 81, 1191\u20131196. https:\/\/doi.org\/10.1212\/WNL.0b013e3182a6cb72 (2013).","journal-title":"Neurology"},{"key":"34910_CR10","doi-asserted-by":"publisher","first-page":"930383","DOI":"10.3389\/fneur.2022.930383","volume":"13","author":"K Kamm","year":"2022","unstructured":"Kamm, K. CGRP and migraine: what have we learned from measuring CGRP in migraine patients so far? Front. Neurol. 13, 930383. https:\/\/doi.org\/10.3389\/fneur.2022.930383 (2022).","journal-title":"Front. Neurol."},{"key":"34910_CR11","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3174\/ajnr.A8208","volume":"45","author":"M Shimoda","year":"2024","unstructured":"Shimoda, M. et al. Cortical hyperperfusion on MRI arterial spin-labeling during the interictal period of patients with migraine headache. AJNR Am. J. Neuroradiol. 45, 686\u2013692. https:\/\/doi.org\/10.3174\/ajnr.A8208 (2024).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"34910_CR12","doi-asserted-by":"publisher","unstructured":"Headache Classification Committee of the International Headache Society (IHS) The international classification of headache Disorders, 3rd edn. Cephalalgia 38 (1-211). https:\/\/doi.org\/10.1177\/0333102417738202 (2018).","DOI":"10.1177\/0333102417738202"},{"key":"34910_CR13","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/head.14153","volume":"61","author":"J Ailani","year":"2021","unstructured":"Ailani, J., Burch, R. C. & Robbins, M. S. The American headache society consensus statement: update on integrating new migraine treatments into clinical practice. Headache 61, 1021\u20131039. https:\/\/doi.org\/10.1111\/head.14153 (2021).","journal-title":"Headache"},{"key":"34910_CR14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3988\/jcn.2008.4.4.158","volume":"4","author":"HE Shin","year":"2008","unstructured":"Shin, H. E., Park, J. W., Kim, Y. I. & Lee, K. S. Headache impact Test-6 (HIT-6) scores for migraine patients: their relation to disability as measured from a headache diary. J. Clin. Neurol. 4, 158\u2013163. https:\/\/doi.org\/10.3988\/jcn.2008.4.4.158 (2008).","journal-title":"J. Clin. Neurol."},{"key":"34910_CR15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2176\/nmc.43.153","volume":"43","author":"R Takeuchi","year":"2003","unstructured":"Takeuchi, R., Yonekura, Y., Takeda, S. K., Fujita, K. & Konishi, J. Fully automated quantification of regional cerebral blood flow with three-dimensional stereotaxic region of interest template: validation using magnetic resonance imaging\u2013technical note. Neurol. Med. Chir. (Tokyo). 43, 153\u2013162. https:\/\/doi.org\/10.2176\/nmc.43.153 (2003).","journal-title":"Neurol. Med. Chir. (Tokyo)"},{"key":"34910_CR16","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2463\/mrms.2013-0117","volume":"13","author":"T Iwanaga","year":"2014","unstructured":"Iwanaga, T. et al. Operator-bias-free comparison of quantitative perfusion maps acquired with pulsed-continuous arterial spin labeling and single-photon-emission computed tomography. Magn. Reson. Med. Sci. 13, 239\u2013249. https:\/\/doi.org\/10.2463\/mrms.2013-0117 (2014).","journal-title":"Magn. Reson. Med. Sci."},{"key":"34910_CR17","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.3174\/ajnr.A3815","volume":"35","author":"Y Inoue","year":"2014","unstructured":"Inoue, Y., Tanaka, Y., Hata, H. & Hara, T. Arterial spin-labeling evaluation of cerebrovascular reactivity to Acetazolamide in healthy subjects. AJNR Am. J. Neuroradiol. 35, 1111\u20131116. https:\/\/doi.org\/10.3174\/ajnr.A3815 (2014).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"34910_CR18","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3174\/ajnr.A1456","volume":"30","author":"M Hauf","year":"2009","unstructured":"Hauf, M. et al. Cortical regional hyperperfusion in nonconvulsive status epilepticus measured by dynamic brain perfusion CT. AJNR Am. J. Neuroradiol. 30, 693\u2013698. https:\/\/doi.org\/10.3174\/ajnr.A1456 (2009).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"34910_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.seizure.2021.08.002","volume":"92","author":"G Giovannini","year":"2021","unstructured":"Giovannini, G. et al. Cortical and thalamic hyper-perfusion in non-convulsive status epilepticus. Relationship between perfusion CT patterns and Salzburg EEG criteria. Seizure 92, 10\u201317. https:\/\/doi.org\/10.1016\/j.seizure.2021.08.002 (2021).","journal-title":"Seizure"},{"key":"34910_CR20","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1038\/jcbfm.2012.110","volume":"32","author":"Y Kaku","year":"2012","unstructured":"Kaku, Y. et al. Cerebral blood flow and metabolism of hyperperfusion after cerebral revascularization in patients with Moyamoya disease. J. Cereb. Blood Flow. Metab. 32, 2066\u20132075. https:\/\/doi.org\/10.1038\/jcbfm.2012.110 (2012).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"34910_CR21","doi-asserted-by":"publisher","first-page":"fcaa223","DOI":"10.1093\/braincomms\/fcaa223","volume":"3","author":"S Ohtomo","year":"2021","unstructured":"Ohtomo, S. et al. Hyperperfusion in the thalamus on arterial spin labelling indicates non-convulsive status epilepticus. Brain Commun. 3, fcaa223. https:\/\/doi.org\/10.1093\/braincomms\/fcaa223 (2021).","journal-title":"Brain Commun."},{"key":"34910_CR22","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/s0022-3999(","volume":"48","author":"CR Soldatos","year":"2000","unstructured":"Soldatos, C. R., Dikeos, D. G. & Paparrigopoulos, T. J. Athens insomnia scale: validation of an instrument based on ICD-10 criteria. J. Psychosom. Res. 48, 555\u2013560. https:\/\/doi.org\/10.1016\/s0022-3999( (2000). 00)00095\u2009\u2013\u20097.","journal-title":"J. Psychosom. Res."},{"key":"34910_CR23","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1080\/08039480801962681","volume":"62","author":"TO Arnarson","year":"2008","unstructured":"Arnarson, T. O., Olason, D. T., Sm\u00e1ri, J. & Sigurethsson, J. F. The Beck depression inventory second edition (BDI-II): psychometric properties in Icelandic student and patient populations. Nord J. Psychiatry. 62, 360\u2013365. https:\/\/doi.org\/10.1080\/08039480801962681 (2008).","journal-title":"Nord J. Psychiatry"},{"key":"34910_CR24","doi-asserted-by":"publisher","unstructured":"Buse, D. C., Rupnow, M. F. & Lipton, R. B. Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life. Mayo Clin. Proc. 84, 422\u2013435. https:\/\/doi.org\/10.1016\/s0025-6196(11)60561-2 (2009).","DOI":"10.1016\/s0025-6196(11)60561-2"},{"key":"34910_CR25","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2214\/ajr.149.2.351","volume":"149","author":"F Fazekas","year":"1987","unstructured":"Fazekas, F., Chawluk, J. B., Alavi, A., Hurtig, H. I. & Zimmerman, R. A. MR signal abnormalities at 1.5 T in alzheimer\u2019s dementia and normal aging. AJR Am. J. Roentgenol. 149, 351\u2013356. https:\/\/doi.org\/10.2214\/ajr.149.2.351 (1987).","journal-title":"AJR Am. J. Roentgenol."},{"key":"34910_CR26","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s10194-023-01567-4","volume":"24","author":"L. Al-Hassany","year":"2023","unstructured":"Al-Hassany, L. et al. Future targets for migraine treatment beyond CGRP. J. Headache Pain. 24, 76 https:\/\/doi.org\/10.1186\/s10194-023-01567-4 (2023).","journal-title":"J. Headache Pain"},{"key":"34910_CR27","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1056\/NEJMoa2314577","volume":"391","author":"M Ashina","year":"2024","unstructured":"Ashina, M., Phul, R., Khodaie, M., L\u00f6f, E. & Florea, I. A monoclonal antibody to PACAP for migraine prevention. N Engl. J. Med. 391, 800\u2013809. https:\/\/doi.org\/10.1056\/NEJMoa2314577 (2024).","journal-title":"N Engl. J. Med."},{"key":"34910_CR28","doi-asserted-by":"publisher","first-page":"e2260","DOI":"10.1002\/brb3.2260","volume":"11","author":"C Baraldi","year":"2021","unstructured":"Baraldi, C., Castro, F. L., Cainazzo, M. M., Pani, L. & Guerzoni, S. Predictors of response to erenumab after 12 months of treatment. Brain Behav. 11, e2260. https:\/\/doi.org\/10.1002\/brb3.2260 (2021).","journal-title":"Brain Behav."},{"key":"34910_CR29","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s10194-021-01333-4","volume":"22","author":"S Bottiroli","year":"2021","unstructured":"Bottiroli, S. et al. Psychological predictors of negative treatment outcome with erenumab in chronic migraine: Data from an open label long-term prospective study. J. Headache Pain. 22, 114. https:\/\/doi.org\/10.1186\/s10194-021-01333-4 (2021).","journal-title":"J. Headache Pain"},{"key":"34910_CR30","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1046\/j.1468-2982.1995.1505373.x","volume":"15","author":"L Edvinsson","year":"1995","unstructured":"Edvinsson, L., Jansen Olesen, I., Kingman, T. A., McCulloch, J. & Uddman, R. Modification of vasoconstrictor responses in cerebral blood vessels by lesioning of the trigeminal nerve: possible involvement of CGRP. Cephalalgia 15, 373\u2013383. https:\/\/doi.org\/10.1046\/j.1468-2982.1995.1505373.x (1995).","journal-title":"Cephalalgia"},{"key":"34910_CR31","doi-asserted-by":"publisher","first-page":"5731","DOI":"10.1073\/pnas.83.15.5731","volume":"83","author":"J. McCulloch","year":"1986","unstructured":"McCulloch, J., Uddman, R., Kingman, T. A. & Edvinsson, L. Calcitonin gene-related peptide: Functional role in cerebrovascular regulation. Proc. Natl. Acad. Sci. U S A. 83, 5731\u20135735. https:\/\/doi.org\/10.1073\/pnas.83.15.5731 (1986).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"34910_CR32","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/ana.25831","volume":"88","author":"IA Mulder","year":"2020","unstructured":"Mulder, I. A. et al. Anti-migraine calcitonin gene-related peptide receptor antagonists worsen cerebral ischemic outcome in mice. Ann. Neurol. 88, 771\u2013784. https:\/\/doi.org\/10.1002\/ana.25831 (2020).","journal-title":"Ann. Neurol."},{"key":"34910_CR33","doi-asserted-by":"crossref","unstructured":"Shimoda, M. et al. MRI-ASL-based CBF changes during the interictal period after anti-CGRP therapy in migraine patients. Preprint at (2024). https:\/\/www.researchsquare.com\/article\/rs-5069054\/v1.","DOI":"10.21203\/rs.3.rs-5069054\/v1"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34910-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34910-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34910-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:53:55Z","timestamp":1770112435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34910-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["34910"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-34910-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All study protocols were approved by the Institutional Review Board for Clinical Research (approval no. 22R-078) and the Conflict of Interest Management Committee (approval no. 22\u2013168) at our university. The study protocol was implemented in accordance with the 1964 Declaration of Helsinki and its later amendments, and all patients provided written informed consent before participating in the study. For all migraine patients, written informed consent for participation was obtained for the prospective study of data acquired during routine medical treatments on the basis of national legislation and institutional requirements. Our report complies with the \u201cStrengthening the Reporting of Observational Studies in Epidemiology\u201d (STROBE) statement for cohort studies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All participants in the study consented to publication of the data obtained in relation to the present study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"A previous version of this paper was published as a preprint titled \u201cMRI-ASL-based CBF changes during the interictal period after anti-CGRP therapy in migraine patients\u201d\n                      33\n                      .","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publication as a preprint"}}],"article-number":"4699"}}